Fount Bio
PrivateLast Round
Series A
Feb 28, 2022
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Fount Bio is a life sciences company that develops innovative, glycopolymer-based products for medical aesthetics and consumer beauty applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fount Bio Comparables
Compare Fount Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eirion Therapeutics | 78% | |
| Innoture | 67% | |
| Teoxane Laboratories | 66% | |
Fount Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 28, 2022 |
Fount Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 32% month-over-month.
- Apr 17, 2026
Monthly visitors grew 6400% MoM, from 18 to 1.2K.
Fount Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fount Bio's valuation, stock price, and market status.